Medicare Part D support cut amid rising retiree costs

As older Americans continue to grapple with escalating housing expenses, a higher overall cost of living and growing health care costs, new Medicare Part D figures for 2027 could further influence household budgets.

Adding to that financial picture, the Trump administration announced it will end a temporary Medicare Part D premium stabilization program after the 2026 contract year, returning standalone prescription drug plans to traditional market conditions beginning in 2027.

The Centers for Medicare & Medicaid Services (CMS) announced the change alongside the release of preliminary technical Medicare Part D bid information for the 2027 contract year.

The voluntary Part D Premium Stabilization Demonstration was introduced in 2025 following benefit changes required under the Inflation Reduction Act — designed to reduce premium volatility for standalone prescription drug plans as insurers adapted to the redesigned Part D benefit.

According to CMS, insurers now have sufficient experience under the updated benefit structure to accurately develop bids without additional support.

As a result, the agency said the initiative will conclude at the end of 2026, with the standalone Part D market returning to its traditional operating framework in 2027.

In a social media post, CMS Administrator Dr. Mehmet Oz said beneficiaries would continue to have access to affordable prescription drug coverage, adding that most enrollees are expected to see monthly premium increases of less than $10, while some plans could cost even less than they do today.

Oz also faulted the Biden administration for creating the subsidy program, arguing it improperly steered federal dollars to insurers. He called the policy “unacceptable” and said it “gave BILLIONS of taxpayer money DIRECTLY to Big Insurance Companies.”

Even relatively modest changes in Medicare-related costs can influence retirement finances, potentially increasing interest in financial planning strategies — including reverse mortgages — that allow eligible homeowners to convert home equity into additional cash flow while remaining in their homes.

Inflation Reduction Act protections remain

Although the premium stabilization demonstration is ending, premium protections established under the Inflation Reduction Act remain in effect.

Under the law, annual increases in the national base beneficiary premium are limited between 2024 and 2029.

The statutory provision caps yearly increases at no more than 6%, helping moderate premium growth even as prescription drug costs and benefit changes continue to evolve.

For retirees already coping with higher mortgage payments, property taxes, homeowners insurance and other everyday expenses, health care remains another key pressure on fixed-income budgets.

This article was written by Jonathan Delozier and generated with the assistance of HousingWire Automation. It was reviewed by a HousingWire editor before publication.